Literature DB >> 25429885

Parthenolide could become a promising and stable drug with anti-inflammatory effects.

Mengting Wang1, Qiyan Li.   

Abstract

The aim of this paper is to summarise the blocking effects of parthenolide on the cytokines and pathways that cause inflammation. Analyses of the chemical structure of parthenolide have tried to identify the active domains that play key roles in its anti-inflammatory activity. This review focuses on the anti-inflammatory actions of parthenolide in both in vitro and in vivo. These data will be helpful for future investigations into the effects of parthenolide on inflammation.

Entities:  

Keywords:  anti-inflammation; chemical structure; parthenolide; pharmacology

Mesh:

Substances:

Year:  2014        PMID: 25429885     DOI: 10.1080/14786419.2014.981541

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  8 in total

Review 1.  Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties.

Authors:  Daniela Carlisi; Marianna Lauricella; Antonella D'Anneo; Anna De Blasio; Adriana Celesia; Giovanni Pratelli; Antonietta Notaro; Giuseppe Calvaruso; Michela Giuliano; Sonia Emanuele
Journal:  Biomedicines       Date:  2022-02-21

2.  Parthenolide plays a protective role in the liver of mice with metabolic dysfunction‑associated fatty liver disease through the activation of the HIPPO pathway.

Authors:  Weihong Wang; Yukai He; Qiuli Liu
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

3.  Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis.

Authors:  Zhihui Zhang; Kai Zhang; Mi Zhang; Xiaomin Zhang; Rongxin Zhang
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

Review 4.  Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.

Authors:  Chang Hoon Lee
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

5.  Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.

Authors:  Mohsen Bahrami; Mohammad Kamalinejad; Seied Amirhossein Latifi; Farhad Seif; Majid Dadmehr
Journal:  Phytother Res       Date:  2020-06-27       Impact factor: 6.388

6.  Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner.

Authors:  Yao-Jiang Liu; Bo Tang; Feng-Chao Wang; Li Tang; Yuan-Yuan Lei; Ya Luo; Sheng-Jie Huang; Min Yang; Ling-Yi Wu; Wei Wang; Shuang Liu; Shi-Ming Yang; Xiao-Yan Zhao
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

7.  Parthenolide Has Negative Effects on In Vitro Enhanced Osteogenic Phenotypes by Inflammatory Cytokine TNF-α via Inhibiting JNK Signaling.

Authors:  Jin-Ho Park; Young-Hoon Kang; Sun-Chul Hwang; Se Heang Oh; June-Ho Byun
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

8.  Investigation of Leoligin Derivatives as NF-κΒ Inhibitory Agents.

Authors:  Thomas Linder; Eleni Papaplioura; Diyana Ogurlu; Sophie Geyrhofer; Scarlet Hummelbrunner; Daniel Schachner; Atanas G Atanasov; Marko D Mihovilovic; Verena M Dirsch; Michael Schnürch
Journal:  Biomedicines       Date:  2021-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.